Source:http://linkedlifedata.com/resource/pubmed/id/19884824
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-11-25
|
pubmed:abstractText |
In spite of great scientific advances, cardiovascular disease is the commonest cause of death worldwide and current cardiovascular prevention strategies fail to achieve the full potential of risk modification. A large amount of evidence supports the use of pharmacological treatments both in primary and secondary prevention and it was hypothesized that a fixed-dose combination of such drugs, a 'polypill', may greatly simplify and improve current prevention strategies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1473-6535
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
453-9
|
pubmed:meshHeading |
pubmed-meshheading:19884824-Antihypertensive Agents,
pubmed-meshheading:19884824-Aspirin,
pubmed-meshheading:19884824-Cardiovascular Diseases,
pubmed-meshheading:19884824-Drug Combinations,
pubmed-meshheading:19884824-Humans,
pubmed-meshheading:19884824-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19884824-Myocardial Ischemia,
pubmed-meshheading:19884824-Primary Prevention,
pubmed-meshheading:19884824-Secondary Prevention,
pubmed-meshheading:19884824-Stroke
|
pubmed:year |
2009
|
pubmed:articleTitle |
Polypill: the evidence and the promise.
|
pubmed:affiliation |
Population Health Research Institute and Department of Medicine, Division of Cardiology, McMaster University, Hamilton, Ontario, Canada. Eva.Lonn@phri.ca
|
pubmed:publicationType |
Journal Article,
Review
|